Johnny Awwad (Sidra Medicine - Qatar) and Mohammad Aboulghar (Egyptian IVF-ET Center, Egypt)
Fertility treatment has come a long way in recent years, with significant technological developments and innovative interventions designed with the promise of improving the success rate and treatment experience for couples struggling with starting a family. Ground-breaking advancements have largely stemmed from extensive research in various experimental models before making their way into clinical practice. In addition to their intended goal of advancing our ability to alter reproductive pathways, these technologies have greatly expanded our understanding of the biology of reproduction. Some, nonetheless, have been hastily introduced into clinical practice with limited evidence to their usefulness, often driven by pressure to try promising innovations before the evidence is available to support their use. Such poorly validated clinical habits brisk of increasing dramatically IVF costs, reducing its affordability and access.
This precongress course discusses some of the innovative technologies which made their way into ART practice in recent years, with the prime focus of evaluating their clinical relevance to improving live births in view of emerging scientific evidence.
Fertility specialists, urologists, embryologists, nurses, business partners, and legal professionals.
Educational needs and expected outcomes
Expected educational outcomes and competencies: Interprofessional (Teams and Teamwork); Physician (Medical Knowledge, Practice-based Learning and Improvement).
After participating in this CME precongress activity, participants should be able to:
Share this page